The genetics of autoimmune thyroid disease

Trends in Endocrinology and Metabolism

Volumn 15, Issue 5, 2004, Pages 234-239

  Ayadi, Hammadi ^a   Kacem, Hassen Hadj ^a   Rebai, Ahmed ^b   Farid, Nadir R ^c  

^a UNIVERSITY OF SFAX   (Tunisia)

^b CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

^c Osancor Biotech Inc   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; AUTOIMMUNE DISEASE; DATA ANALYSIS; DATA BASE; GENE LOCUS; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC STRAIN; GRAVES DISEASE; HASHIMOTO DISEASE; HISTOCOMPATIBILITY COMPLEX; HUMAN; MOLECULAR GENETICS; NONHUMAN; PATHOGENICITY; PATIENT REFERRAL; PRIORITY JOURNAL; REVIEW;

AUTOIMMUNE DISEASES; CHROMOSOME MAPPING; HUMANS; LINKAGE (GENETICS);

EID: 3042574710     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2004.05.002     Document Type: Review

References (70)

1. Farid N.R., Marga M. Genetics of thyroid-associated ophthalmopathy: a play in search of a cast of characters. J. Endocrinol. Invest. 26:2003;570-574
2. Maalej A., et al. A full genome screening in a large Tunisian family affected with thyroid autoimmune disorders. Genes Immun. 2:2001;71-75
3. Farid N.R. Graves' disease. Farid N.R. HLA in Endocrine and Metabolic Diseases. 1981;86-121 Academic Press
4. Stenszky V., et al. The genetics of Graves' disease: HLA and disease susceptibility. J. Clin. Endocrinol. Metab. 61:1985;735-740
5. Brix T.H., et al. What is the evidence of genetic factors in the etiology of Graves' disease? A brief review. Thyroid. 8:1998;627-634
6. Onengut-Gumuscu S., Concannon P. Mapping of genes for autoimmunity in humans: type1 diabetes as a model. Immunol. Rev. 190:2002;182-194
7. Brix T.H., et al. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J. Clin. Endocrinol. Metab. 86:2001;930-934
8. Brix T.H., et al. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J. Clin. Endocrinol. Metab. 85:2000;536-539
9. Farid N.R., Bear J.C. The human major histocompatibility complex and endocrine disease. Endocr. Rev. 2:1981;50-86
10. Tomer Y., Davies T.F. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev. 24:2003;694-717
11. Marga M., et al. Two HLA-DRB1 alleles confer independent susceptibility to Graves' disease: relevance of cross-population studies. Am. J. Med. Genet. 102:2001;188-191
12. Christiakov D.A., Turakulov R.L. CTLA-4 and its role in autoimmune thyroid disease. J. Mol. Endocrinol. 31:2003;21-36
13. Vaidya B., et al. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum. Mol. Genet. 8:1999;1195-1199
14. Tomer Y., et al. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J. Clin. Endocrinol. Metab. 86:2001;1687-1693
15. Einardottir E., et al. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease. Eur. J. Hum. Genet. 11:2003;81-84
16. Ueda H., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 423:2003;506-511
17. Kelso A. Cytokines: principles and prospects. Immunol. Cell Biol. 76:1998;300-317
18. Hunt P.J., et al. Cytokine gene polymorphisms in autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 85:2000;1984-1988
19. Blakemore A.I., et al. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J. Clin. Endocrinol. Metab. 80:1995;111-115
20. Chistyakov D.A., et al. Complex association analysis of Graves disease using a set of polymorphic markers. Mol. Genet. Metab. 70:2000;214-218
21. Cuddihy R.M., Bahn R.S. Lack of an association between alleles of interleukin-1α and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population. J. Clin. Endocrinol. Metab. 81:1996;4476-4478
22. Heward J.M., et al. The interleukin-1 receptor antagonist gene shows no allelic association with three autoimmune diseases. Thyroid. 9:1999;627-628
23. Heward J.M., et al. No association of an interleukin-4 gene promoter polymorphism with Graves' disease in the United Kingdom. J. Clin. Endocrinol. Metab. 86:2001;3861-3863
24. Tomer Y., et al. A new Graves disease-susceptibility locus maps to chromosome 20q11.2. Am. J. Hum. Genet. 63:1998;1749-1756
25. Tomer Y., et al. A C/t single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid. 12:2002;1129-1135
26. Ban Y., et al. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid. 10:2000;475-480
27. Ban Y., et al. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J. Clin. Endocrinol. Metab. 85:2000;4639-4643
28. Ban Y., et al. Vitamin D receptor gene polymorphisms in Hashimoto's thyroiditis. Thyroid. 11:2001;607-608
29. McDermott M.F., et al. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia. 40:1997;971-975
30. Fukazawa T., et al. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J. Neurol. Sci. 166:1999;47-52
31. Farid N.R., et al. Gm phenotypes in autoimmune thyroid disease. J. Immunogenet. 4:1977;429-432
32. Nakao Y., et al. IgG heavy chain allotypes (Gm) in atrophic and goitrous thyroiditis. J. Immunogenet. 9:1982;311-316
33. Uno H., et al. Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature. 292:1981;768-770
34. Farid N.R., Bear J.C. Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature. 295:1982;629
35. De Roux N., et al. Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease. J. Clin. Endocrinol. Metab. 81:1996;3483-3486
36. Cuddihy R.M., et al. A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid. 5:1995;89-95
37. Sale M.M., et al. Association of autoimmune thyroid disease with a microsatellite marker for the thyropin receptor gene and CTL-A4 in a Japanese population. Proc. Assoc. Am. Physicians. 109:1997;453-461
38. Watson P.F., et al. Lack of association between a polymorphism in the coding region of the thyrotropin receptor gene and Graves' disease. J. Clin. Endocrinol. Metab. 80:1995;1032-1035
39. Tomer Y., et al. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J. Clin. Endocrinol. Metab. 87:2002;404-407
40. Sakai K., et al. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum. Mol. Genet. 10:2001;1379-1386
41. Pirro M.T., et al. Thyroperoxidase microsatellite polymorphism in thyroid diseases. Thyroid. 5:1995;461-464
42. Hadj Kacem H., et al. PDS is a new susceptibility gene to autoimmune thyroid diseases: association and linkage study. J. Clin. Endocrinol. Metab. 88:2003;2274-2280
43. Allen E.M., et al. genome-wide scan for autoimmune thyroiditis in the Old Order Amish: replication of genetic linkage on chromosome 5q11.2-q14.3. J. Clin. Endocrinol. Metab. 88:2003;1292-1296
44. Jin Y., et al. Genome-wide scan of Graves' disease: evidence for linkage on chromosome 5q31 in Chinese Han pedigrees. J. Clin. Endocrinol. Metab. 88:2003;1798-1803
45. Lander E., Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11:1995;241-247
46. Risch N.J. Searching for genetic determinants in the new millennium. Nature. 405:2000;847-856
47. Lohmueller K.E., et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33:2003;177-182
48. Tomer Y., et al. Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J. Clin. Endocrinol. Metab. 82:1997;1645-1648
49. Tomer Y., et al. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J. Clin. Endocrinol. Metab. 84:1999;4656-4664
50. Barbesino G., et al. Linkage analysis of candidate genes in autoimmune thyroid disease. II. Selected gender-related genes and the X chromosome. International Consortium for the Genetics of Autoimmune Thyroid Disease. J. Clin. Endocrinol. Metab. 83:1998;3290-3295
51. Pearce S.H., et al. Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves disease. Am. J. Hum. Genet. 65:1999;1462-1465
52. Vaidya B., et al. Evidence for a new Graves disease susceptibility locus at chromosome 18q21. Am. J. Hum. Genet. 66:2000;1710-1714
53. Imrie H., et al. Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population. J. Clin. Endocrinol. Metab. 86:2001;626-630
54. Tomer Y., et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am. J. Hum. Genet. 73:2003;736-747
55. Villanueva R., et al. Autoimmune thyroid disease susceptibility loci in a large Chinese family. Clin. Endocrinol. (Oxf.). 56:2002;45-51
56. Ban Y., et al. The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families. Clin. Endocrinol. (Oxf.). 57:2002;81-88
57. Alkhateeb A., et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum. Mol. Genet. 11:2002;661-667
58. Allen A.S., et al. Informative missingness in genetic association studies: case-parent designs. Am. J. Hum. Genet. 72:2003;671-680
59. Emahazion T., et al. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet. 17:2001;407-413
60. Pritchard J.K., et al. Association mapping in structured populations. Am. J. Hum. Genet. 67:2000;170-181
61. Devlin B., Roeder K. Genomic control for association studies. Biometrics. 55:1999;997-1004
62. Greenberg D.A., et al. Power, mode of inheritance, and type I error in LOD scores and affecteds-only methods: reply to Kruglyak. Am. J. Hum. Genet. 62:1998;202-204
63. Abreu P.C., et al. Direct power comparisons between simple LOD scores and NPL scores for linkage analysis in complex diseases. Am. J. Hum. Genet. 65:1999;847-857
64. Sham P.C., et al. Power comparison of parametric and nonparametric linkage tests in small pedigrees. Am. J. Hum. Genet. 66:2000;1661-1668
65. Xiong M., Guo S.W. The power of linkage detection by the transmission/disequilibrium tests. Hum. Hered. 48:1998;295-312
66. Spielman R.S., et al. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:1993;506-516
67. Fan R., Knapp M. Genome association studies of complex diseases by case-control designs. Am. J. Hum. Genet. 72:2003;850-868
68. Slager S.L., et al. Effect of allelic heterogeneity on the power of the transmission disequilibrium test. Genet. Epidemiol. 18:2000;143-156
69. Mitchell A.A., et al. Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test. Am. J. Hum. Genet. 72:2003;598-610
70. Ioannidis J.P., et al. Replication validity of genetic association studies. Nat. Genet. 29:2001;306-309